A professional news service dedicated to publishing up-to date-information regarding infection causing agents, anti-infective products and therapies.
Abunasser J et al. – The results showed a survival benefit only for linezolid, despite the fact that all three antibiotics had levels above MIC in all the compartments sampled, leading them to speculate that linezolid may have improved outcomes by mechanisms not directly related to its antimicrobial actions. read more
Raad I et al. – CVC retention does not have an impact on the resolution of coagulase–negative staphylococcal bacteremia but is a significant risk factor of recurrence. read more
Sader HS et al. – High rates of methicillin–resistant staphylococci and vancomycin–resistant enterococci were observed in US hospitals, but daptomycin remains active against these clinically important Gram–positive organisms with no evidence of potency loss since its approval for clinical use in late 2003. read more
Guerrero DM et al. – As the prevalence of A. baumannii continues to increase in the health care system, SSTIs caused by this organism may become more common. Clinicians must be aware that the spectrum of disease caused by A. baumannii could include severe necrotizing SSTI and that vigilance for potential complications is necessary. read more
